The last set of market developments for
Colgate-Palmolive Company (CL) has stirred differing opinions among market experts.
RBC Capital has upgraded the stock to outperform, citing the company's promise of long-term growth. This has led several asset management firms including
Balyasny and
BI Asset Management Fondsmaeglerselskab A S to increase their stake significantly. Reassessing
CL's valuation after a recent 16% slide, a
DCF analysis anticipates a 36.7% upside in 2025, suggesting a rebound in this Dividend King. However, Argus has downgraded the company to 'hold' due to challenges with margins. The dividend maintains at $0.52 quarterly, while
RBC's confidence in
CL's margins and cash flow have altered its investment story. Additionally,
CL and Erthos are cooperating to develop sustainable biopolymer packaging. Despite unfavorable quarterly sales affected by consumers' price hike resistance, Bank of America remains positive on
CL's future due to core brands and pet nutrition segment.
Colgate-Palmolive Company CL News Analytics from Tue, 29 Apr 2025 07:00:00 GMT to Sat, 13 Dec 2025 19:20:38 GMT -
Rating 4
- Innovation 3
- Information 7
- Rumor -2
